Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-86.08M -112.67M -133.2M -151.08M
Depreciation & Amortization
1.72M 2.14M 2.27M 1.98M
Stock-Based Compensation
9.22M 24.98M 31.14M 26.21M
Other Working Capital
-19.42M 10.02M 2.15M 1.57M
Other Non-Cash Items
27.6M 1.1M 2.69M 2.59M
Deferred Income Tax
n/a n/a n/a 4M
Change in Working Capital
-17.89M 5.88M 6.18M -1.62M
Operating Cash Flow
-65.44M -78.58M -90.93M -117.92M
Capital Expenditures
-4K -679K -577K -4.26M
Cash Acquisitions
n/a n/a 31.64M -67.98M
Purchase of Investments
-89.23M -212.96M -367.12M -177.73M
Sales Maturities Of Investments
174.67M 280M 335.48M 245.72M
Other Investing Acitivies
n/a n/a -31.64M 67.98M
Investing Cash Flow
85.44M 66.37M -32.22M 63.72M
Debt Repayment
n/a n/a n/a -5K
Common Stock Repurchased
244K 538K 380K 1.34M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
245K 567K 851K 4.46M
Financial Cash Flow
245K 567K 851K 4.46M
Net Cash Flow
20.25M -11.65M -122.3M -49.74M
Free Cash Flow
-65.44M -79.26M -91.5M -122.18M